Long term prognostic value of the Fibro Test in patients with non-alcoholic-fatty-liver disease (Nafld) , compared to chronic hepatitis C (Chc) , B (Chb) , and alcoholic liver disease (Ald)
Munteanu, M.; Moussalli, J.; Rudler, M.; Lebray, P.; Perazzo, H.; Massard, J.; Pais, R.; Charlotte, F.; Thibault, V.; Olivier, L.; Hannoun, L.; Valantin, M.A.; Ngo, Y.; Drane, F.; Bismut, F.I.
Journal of Hepatology 68: S99-S100
2018
ISSN/ISBN: 0168-8278 DOI: 10.1016/s0168-8278(18)30419-7
Accession: 067124568
PDF emailed within 0-6 h: $19.90
Related References
Munteanu, M.; Pais, R.; Peta, V.; Deckmyn, O.; Moussalli, J.; Ngo, Y.; Rudler, M.; Lebray, P.; Charlotte, F.; Thibault, V.; Lucidarme, O.; Ngo, A.; Imbert-Bismut, F.ço.; Housset, C.; Thabut, D.; Ratziu, V.; Poynard, T. 2018: Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease Alimentary Pharmacology and Therapeutics 48(10): 1117-1127Golabi, P.; Paik, J.M.; Eberly, K.; de Avila, L.; Alqahtani, S.A.; Younossi, Z.M. 2022: Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C Annals of Hepatology 27(1): 100556
Estakhri, A.; Sari, A.A.; Nedjat, S.N.; Rohban, M.; Rakhshani, N.; Tavangar, S.M.; Malekzadeh, R.; Montazeri, G. 2012: The effect of NAFLD (non-alcoholic fatty liver disease) on long-term outcome of chronic hepatitis B in Iranian patients Open Journal of Gastroenterology 02(01): 18-21
Ratziu, V.; Lecalvez, S.; Imbert-Bismut, F.; Messous, D.; Charlotte, F.; Bonyhay, L.; Munteanu, M.; Poynard, T. 2003: Diagnostic value of biochemical markers (fibrotest) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease (Nafld) Hepatology 38(Supp S): 510-511
Derakhshandeh-Rishehri, S.M.; Heidari-Beni, M.; Eftekhari, M.H. 2020: The effects of Realsil (Silybin-Phospholipid-Vitamin e Complex) on Liver Enzymes in Patients with Non-Alcoholic Fatty Liver Disease (Nafld) or Non-Alcoholic Steato-Hepatitis (Nash): a Systematic Review and Meta-Analysis of Rcts Acta Endocrinologica 16(2): 223-231
Cocciolillo, S.; DiTullio, A.M.; Pagliaro, M.; Tavani, R.; di Berardino, M.; Sepe, A.; Ciccaglione, A.F.; Grossi, L.; Parruti, G.; Marzio, L. 2015: Evaluation Through Fibro Scan and Contrast Enhanced Ultrasound (Ceus) of Liver Stiffness and Liver Parenchyma Blood Flow in Non Alcoholic Fatty Liver Disease (Nafld), Chronic Hepatitis C (Chc) Without Cirrhosis vs Normal Controls Gastroenterology 148(4): S-170-S-171
Watt, J.; Kurth, M.J.; Reid, C.N.; Lamont, J.V.; Fitzgerald, P.; Ruddock, M.W. 2022: Non-alcoholic fatty liver disease-A pilot study investigating early inflammatory and fibrotic biomarkers of NAFLD with alcoholic liver disease Frontiers in Physiology 13: 963513
Brain, D.; O'Beirne, J.; Hickman, I.J.; Powell, E.E.; Valery, P.C.; Kularatna, S.; Tulleners, R.; Farrington, A.; Horsfall, L.; Barnett, A. 2020: Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD) Bmc Health Services Research 20(1): 335
Canbay, A.; Bechmann, L.P.; Best, J.; Jochum, C.; Treichel, U.; Gerken, G. 2006: Crohn's disease-induced non-alcoholic fatty liver disease (NAFLD) sensitizes for severe acute hepatitis B infection and liver failure Zeitschrift für Gastroenterologie 44(3): 245-248
Pérez-Carreras, M.; Muñoz Codoceo, C.; Ortega, M.M.; Castro, M.R.; Alfonso, F.M.; Algibez, A.M.; Gil, Y.R.; Tortajada, G.C. 2018: Temporal assessment of the non-invasive fibrosis scores Fib-4 and Non-Alcoholic Fatty Liver Disease Fibrosis Score (Nfs) in a retrospective cohort study among patients with Non-Alcoholic Fatty Liver Disease (Nafld) Journal of Hepatology 68: S565-S566
Choudhary, N.S.; Duseja, A. 2021: Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) Translational Gastroenterology and Hepatology 6: 2
Liang, W.; Chikritzhs, T.; Pascal, R.; Binns, C.W. 2011: Mortality rate of alcoholic liver disease and risk of hospitalization for alcoholic liver cirrhosis, alcoholic hepatitis and alcoholic liver failure in Australia between 1993 and 2005 Internal Medicine Journal 41(1a): 34-41
Codjia, T.; Rebibo, L.; François, A.; Lagnel, C.; Huet, E.; Bekri, S.; Pattou, F.ço.; Régimbeau, J.-M.; Schwarz, L. 2021: Evolution of Non-alcoholic Fatty Liver Disease (NAFLD) Biomarkers in Response to Weight Loss 1 year After Bariatric Surgery-a Post Hoc Analysis of the FibroTest Prospective Study Obesity Surgery 31(8): 3548-3556
Tana, C.; Tana, M.; Rossi, S.; Silingardi, M.; Schiavone, C. 2016: Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution Journal of Ultrasound 19(3): 183-189
Zelber-Sagi, S.; Nitzan-Kaluski, D.; Goldsmith, R.; Webb, M.; Blendis, L.; Halpern, Z.; Oren, R. 2007: Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study Journal of Hepatology 47(5): 711-717
Hachemi, M.,Benmakhlouf, S.,Prost, P.,Santolaria, N.… 2017: LaNon Alcoholic Fatty Liver Disease(NAFLD) et laNon Alcoholic Steato-Hepatitis(NASH) des pathologies de systme : revue pour le ranimateur Réanimation 26(1): 63-74
Younossi, Z.M.; Stepanova, M.; Henry, L.; Racila, A.; Lam, B.; Pham, H.T.; Hunt, S. 2017: A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD Liver International: Official Journal of the International Association for the Study of the Liver 37(8): 1209-1218
Wang, J.; Li, P.; Jiang, Z.; Yang, Q.; Mi, Y.; Liu, Y.; Shi, R.; Zhou, Y.; Wang, J.; Lu, W.; Li, S.; Liu, D. 2016: Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD Korean Journal of Internal Medicine 31(3): 479-487
Kaya, E.; Zedginidze, A.; Bechmann, L.; Canbay, A. 2022: Metabolic dysfunction-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD): distinct fatty liver entities with different clinical outcomes? Hepatobiliary Surgery and Nutrition 11(2): 299-301
Shoreibah, M.; Raff, E.; Bloomer, J.; Kakati, D.; Rasheed, K.; Kuo, Y-Fang.; Singal, A.K. 2016: Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver disease Annals of Hepatology 15(2): 183-189